- Dr. Rami一. Al-Horani的 研究领域是化学, 生化, 药理学设计, 发现, and development of orthosteric peptidomimetics and allosteric glycosaminoglycan mimetics which can serve as novel therapeutics to treat cardiovascular diseases and/or chemical probes to investigate unknown mechanisms of pathological conditions, 特别强调止血和血栓形成.
- Dr. 罗伯特·布莱克的 research focuses on the study of the kinetics and thermodynamics of receptor-ligand binding interactions. 特别是, his lab t has an integrating cavity absorption meter that offers the unique capability to monitor absorbance or fluorescence changes in turbid suspensions that scatter light. These functional studies are complemented with other instrumentation that focuses on the structural characterization of nanoparticles.
- Dr. 沛Bostanian conducts research in the areas of preformulation and formulation of drug delivery systems; he is one of the inventors of a U.S. 小颗粒形成专利. His research has resulted in several peer-reviewed publications with his current research focusing on enhancing the bioavailability of drugs with low water solubility.
- Dr. KiTani Parker Lemieux 's research is aimed at understanding the molecular determinants that are critical in the progression, 迁移, 三阴性乳腺癌(TNBC)的侵袭. The approach is to identify these factors from the noncancerous microenvironment and to determine their role in the proliferation, 迁移, 以及TNBC的入侵.
- Dr. 塔伦K. Mandal 是一位特聘教授, 纳米医学和药物输送中心主任, 也是路易斯安那州疫苗中心的联合主任. He is a Fellow of the American Association of 制药aceutical Scientists. His research focuses on the design and development of commercially viable formulations to improve safety, 功效, 病人的依从性. Cutting-edge research in his laboratory has resulted in patented controlled-release formulations of many therapeutic agents. He has published close to 200 original research papers, reviews, abstracts, and monographs.
- Dr. 汤米C. 莫里斯的 research is focused in the area of transdermal drug delivery systems with emphasis on “drug in adhesive” technology. 使用COX-2抑制剂如塞来昔布, the goal is to study the feasibility of developing a transdermal patch that when applied to specific areas of the body, 比如膝盖, will deliver a sufficient dose locally to alleviate osteoarthritis pain, while limiting systemic absorption and minimizing the adverse effects associated with current oral dose regimens.
- Dr. 耐心Obih research focus currently is in the area of Transcriptional Regulation of Natriuretic Sensitivity in Diabetes Mellitus and Drug Discovery. 她在寻找治疗糖尿病的新药, her laboratory screens medicinal herbs for antidiabetic activities. Projects underway include characterization and purification of the medicinal extracts and examining the samples for inhibition of amylase and alpha-glucosidase as well as Glucose Signaling.
- Dr. Yashoda Pramar conducts research in the area of formulation and stability of drugs in oral and intravenous liquid dosage forms. She has spear-headed nation-wide, collaborative, funded ventures with the compounding industry. 她发表了50多篇同行评议的论文, numerous presentations and a compounded monograph in the USP.
- Dr. Dinithia桑普森的 research focuses on central nervous system (CNS) drug design and development; she engages in providing interdisciplinary research and novel solutions integral to biomedical and 药理 advancements within antipsychotic and Alzheimer's disease/ dementia drug development.
- Dr. 苏尼尔Sirohi的 research focuses on the 发现 and development of improved pharmacotherapeutic agents to treat addictive and related neuropsychiatric disorders. 综合行为, 药理, 生化, and molecular approach is utilized to examine how patterned feeding (over-consumption of palatable food and consequent under-consumption of less preferred food) impacts the brain and behavior.
- Dr. 托马斯·E. 威斯的 research focuses primarily on the molecular mechanisms involved in nuclear receptor mediated endocrine disruption. 正在进行的项目包括该基因的特征描述, receptor and tissue specific effects of hormone-active environmental chemicals, 膳食补充剂和药品. The goal of these studies is to define the endocrine disruption of these substances as primary molecular cellular level events.
- Dr. 克里斯托弗·威廉姆斯的 research focuses on discovering novel therapeutic approaches to the treatment of breast cancer. 具体地说, this includes studies on the impact on Protein Kinase CK2 inhibition on estrogen signaling in breast cancer, as well as the impact of orphan nuclear receptor NURR1 on disease progression in hormone-related cancers. These studies are geared to increasing the therapeutic window for tamoxifen to prevent tumor progression towards endocrine insensitivity, as well as exploring the possibility that NURR1 may serve as a biomarker for cancer dormancy and low likelihood of progression.
- Dr. 贾斯汀•威尔逊的 research interests are in the area of health disparities among populations with a particular focus on hypertension and the role of the kidneys in regulating blood pressure and different metabolic diseases.